https://www.dukehealth.org/clinical-trials/directory/pro00087382
Study of Inotuzumab Ozogamicin in... | Clinical Trials at Duke
We are doing this study to find out what effects (good and/or bad) the study drug Inotuzumab Ozogamicin has on children and young... | View the details of this...
inotuzumab ozogamicinclinical trialsstudyduke
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2016-01494
Inotuzumab Ozogamicin in Treating Younger Patients with B-Lymphoblastic Lymphoma or Relapsed or...
Inotuzumab Ozogamicin in Treating Younger Patients with B-Lymphoblastic Lymphoma or Relapsed or Refractory CD22 Positive B Acute Lymphoblastic Leukemia
inotuzumab ozogamicin
https://www.cincinnatichildrens.org/service/c/clinical-trials/studies/IoVeX-JR-2024-052925
Study of Inotuzumab Ozogamicin, Venetoclax, and Dexamethasone for Relapsed B-cell ALL
The goal of this clinical trial is to learn if the combination of drugs Inotuzumab Ozogamicin, Venetoclax, and Dexamethasone (IoVeX) are safe to treat relapsed...
inotuzumab ozogamicin
https://www.esmo.org/oncology-news/ema-recommends-extension-of-indications-for-inotuzumab-ozogamicin
EMA Recommends Extension of Indications for Inotuzumab Ozogamicin | ESMO
inotuzumab ozogamicinemarecommendsextensionindications
https://www.cancer.gov/publications/dictionaries/cancer-drug/def/inotuzumab-ozogamicin
Definition of inotuzumab ozogamicin - NCI Drug Dictionary - NCI
Find technical definitions and synonyms by letter for drugs/agents used to treat patients with cancer or conditions related to cancer. Each entry includes...
inotuzumab ozogamicindefinitionncidrugdictionary
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2017-00826
Inotuzumab Ozogamicin in Treating Patients with Acute Lymphocytic Leukemia after Transplant - NCI
Inotuzumab Ozogamicin in Treating Patients with Acute Lymphocytic Leukemia after Transplant
acute lymphocytic leukemiainotuzumab ozogamicintreating patients
https://www.medicaldaily.com/pfizer-non-hodgkin-lymphoma-drug-inotuzumab-ozogamicin-fails-late-stage-clinical-trials-246078
Pfizer Non-Hodgkin Lymphoma Drug Inotuzumab Ozogamicin Fails In Late Stage Clinical Trials
May 21, 2013 - Stopped in the middle after a cursory review of data, Pfizer says it won't give up on researching the combination of specific antibody and cell killing agent.
non hodgkin lymphoma
https://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-trial-looking-inotuzumab-ozogamicin-diffuse-large-b-cell-lymphoma-inca
A trial looking at inotuzumab ozogamicin for diffuse large B cell lymphoma (INCA)
This trial is looking at inotuzumab ozogamicin with R-CVP for diffuse large B cell lymphoma.
https://www.mayo.edu/research/clinical-trials/cls-20416407?&p=1
Inotuzumab Ozogamicin In Treating Younger Patients With Relapsed Or Refractory CD22 Positive B...
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCT03150693&r=1
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults with Newly Diagnosed B...
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults with Newly Diagnosed B Acute Lymphoblastic Leukemia